John Stuelpnagel
Oncology
Adaptive Biotechnologies
United States of America
Biography
Dr. John Stuelpnagel co-founded and was Executive Chairman of Ariosa Diagnostics, Inc. until the company was acquired by Roche in 2015. He also served as the Chairman of Sequenta prior to its acquisition by Adaptive Biotechnologies. In 1998 he co-founded Illumina, Inc. and was instrumental in building Illumina into a life sciences industry leader. During his 12 years at Illumina, Dr. Stuelpnagel served as the company’s first CEO and then transitioned into the role of COO. Prior to Illumina, he was a venture capitalist at CW Group. Dr. Stuelpnagel received his B.S. in Biochemistry and his Doctorate in Veterinary Medicine from the University of California, Davis, and holds an M.B.A. from the University of California, Los Angeles.
Research Interest
Oncology
